By proceeding you confirm you are at least 18 years old.
Recent findings suggest that Bifidobacterium also enhances glucose tolerance and insulin sensitivity, indicating therapeutic potential for diabetes management
KLOW blend is discussed in market-oriented settings due to the potential complementary action between multiple known peptide components
Its main actions include: Stimulating insulin secretion from pancreatic beta cells in a glucose-dependent manner Suppressing glucagon release, which reduces hepatic glucose production Slowing gastric emptying, which moderates post-meal glucose spikes Promoting satiety through central nervous system pathways, thereby reducing appetite GIP is released by K-cells in the proximal small intestine and shares some functions with GLP-1, particularly in enhancing insulin secretion after meals
Non-steroidal anti-inflammatory drugs (NSAIDs), including aspirin (ASA) reduce inflammation by inhibiting the synthesis of prostaglandins (PGs) and induce apoptosis in a variety of cancer cells [5], [6], [7].Tumor cells are known to develop resistance towards therapeutic drugs and irradiation due to inhibition of apoptotic stimuli in these cells
